Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer.
Saved in:
| Title: | Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer. |
|---|---|
| Authors: | Zhang W; Office of Academic Research, Qiqihar Medical University, Qiqihar, China., Li J; School of Public Health, Qiqihar Medical University, Qiqihar, China., Gao X; Research Institute of Medicine of Pharmacy, Qiqihar Medical University, Qiqihar, China., Liu L; Research Institute of Medicine of Pharmacy, Qiqihar Medical University, Qiqihar, China., Liang H; School of Public Health, Qiqihar Medical University, Qiqihar, China., Yue L; Office of Academic Research, Qiqihar Medical University, Qiqihar, China. |
| Source: | Frontiers in oncology [Front Oncol] 2025 May 20; Vol. 15, pp. 1602585. Date of Electronic Publication: 2025 May 20 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1602585 |
